CSIMarket


Cognition Therapeutics inc   (NASDAQ: CGTX)
Other Ticker:  
 

Cognition Therapeutics inc

CGTX's Fundamental analysis








Cognition Therapeutics Inc 's sales fell in III. Quarter 2024 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.31 %

Cognition Therapeutics Inc net loss increased from $-7 millions, to $-10 millions in III. Quarter 2024,

More on CGTX's Growth


Cognition Therapeutics Inc
realized a net loss in trailing twelve months.

Cognition Therapeutics Inc realized cash reduction of $ -0.27 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.59.


More on CGTX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.36

Cognition Therapeutics Inc
realized net loss in trailing twelve months.

Cognition Therapeutics Inc realized cash outflow of $ -0.27per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.59.

Cognition Therapeutics Inc Price to Book Ratio is at 1.9 lower than Industry Avg. of 383.35. and higher than S&P 500 Avg. of 0.01

More on CGTX's Valuation

  Market Capitalization (Millions $) 28
  Shares Outstanding (Millions) 40
  Employees 27
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -34
  Cash Flow (TTM) (Millions $) -11
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 0.36

  Market Capitalization (Millions $) 28
  Shares Outstanding (Millions) 40
  Employees 27
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -34
  Cash Flow (TTM) (Millions $) -11
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 2.11
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.9
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com